InterVene: Funding, Investors & Team (Sep 2026)
InterVene Inc. is a medical device company developing interventional technologies to treat and prevent chronic venous insufficiency (CVI) with a focus on deep veins and severe, complex venous diseases. The company’s Recana™ thrombectomy catheter system is designed to recanalize chronically obstructed deep veins and to facilitate treatment of in-stent restenosis, particularly in cases where recanalization options are limited or long-term stent maintenance is required. Recana is an investigational device limited by Federal (US) law to investigational use. Based in Redwood City, California, InterVene has assembled an exemplary team of employees, investors, advisors and board members, all possessing extensive vascular and venous interventional market experience.
InterVene has raised $13.0M across 1 funding round on record, the most recent a Series A of $13.0M announced in Oct 2024.
That round is above the $4.8M median round size for Health Care companies tracked on FundedIQ over the last two years.
InterVene Company Profile and Key Stats
Latest funding round on record: Oct 2024.
InterVene Funding Rounds
InterVene Founders and Leadership Team
No contact details are on record for this team yet.
InterVene Funding Compared to Other Health Care Startups
InterVene's latest round of $13.0M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like InterVene in Health Care and South San Francisco
Companies Similar to InterVene
Thyme Care is an oncology solution that integrates patients and providers, working with health plans to…
https://metriport.com
There are too many reasons why Healthcare is unaffordable in the U.S, but one of the largest is waste. Up to…
Serif Health provides healthcare price intelligence and contract management solution.
Switchboard Health provides virtual care solutions to payers, health systems, employers, and at-risk…
Astek Diagnostics has designed a system that helps doctors choose the right antibiotics for patients…
TECLens is developing a crosslinking technology that can effectively address vision problems in both healthy…
Healthcare Shares operates as a crowdfunding portal for the transformative medical innovations of the future.
Gradient Health collaborates with medical data providers worldwide to assemble diseases and conditions for AI…
Kalivir designs safe and potent oncolytic product candidates across multiple tumor types. Kalivir’s…
Happy Health is a mission-driven technology company committed to transforming mental health awareness through…
Leal Therapeutics creates new treatments for patients.
InterVene Funding FAQs
What does InterVene do?
InterVene Inc. is a medical device company developing interventional technologies to treat and prevent chronic venous insufficiency (CVI) with a focus on deep veins and severe, complex venous diseases. The company’s Recana™ thrombectomy catheter system is designed to recanalize chronically obstructed deep veins and to facilitate treatment of in-stent restenosis, particularly in cases where recanalization options are limited or long-term stent maintenance is required. Recana is an investigational device limited by Federal (US) law to investigational use. Based in Redwood City, California, InterVene has assembled an exemplary team of employees, investors, advisors and board members, all possessing extensive vascular and venous interventional market experience.
How much funding has InterVene raised?
InterVene has raised $13.0M across 1 round on record. The most recent is a Series A of $13.0M announced in Oct 2024.
When did InterVene last raise funding?
InterVene's most recent funding round on record is a Series A of $13.0M, announced in Oct 2024.
Who founded InterVene?
FundedIQ lists Aaron Mccloud (Founder) at InterVene.
Where is InterVene headquartered?
InterVene is based in South San Francisco, California, United States.
How many employees does InterVene have?
InterVene is in the 1-10 employee band.
How does InterVene's funding compare to other Health Care startups?
InterVene's latest round of $13.0M is above the $4.8M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's InterVene Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for InterVene is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.